Back to top

Aggressive Growth

Genomic Health, Inc (GHDX - Analyst Report) shares are doing great after a bullish quarterly report. Analyst estimates are on the rise, pushing GHDX to a Zacks #1 Rank (Strong Buy).

There is always a worry that shares will drop right back down after a sharp increase, but it looks like investors are happy with shares at this higher level.

Company Description

Genomic Health develops genomic-based lab services for cancer patients. The company's Oncotype DX can be used for breast cancer tests to predict recurrence and chemotherapy benefits for breast cancer. Oncotype DX can now also be used for colon cancer, as of this year.

Revenue Up 18%

On Nov 8 Genomic Health reported third-quarter results that showed an 18% increase in revenue, to $46.3 million. Net income was $3.7 million, giving the company back to back profitable quarters.

Earnings broke down to 12 cents per share. There were no estimates for the period, but given the surge in share price, it was better than many expected.

Consensus Jumps

Following the news that full-year Zacks Consensus Estimate for this year jumped into the black, to a 14 cent profit from a 1 cent loss. Next year's forecasts are up a nickel on average, to 31 cents.

Last year the company lost 33 cents per share, so the growth rates are a bit skewed for this year, but earnings should more than double in 2011.

The Chart

Shares of GHDX spiked after the quarterly results were released and thankfully were able to hold onto those gains. You can see that there was some profit taking but the volatility was relatively light and shares have held this level nicely.

Genomic Health - ticker GHDX >
<P ALIGN=

Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Small Cap Trader service

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%